One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-146863
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Dana-Farber Cancer Institute, University of Oslo, Oslo University Hospital, California State University, Fresno, University of California, San Francisco, Institutul Clinic Fundeni, Guglielmo da Saliceto Hospital, Erasmus MC Cancer Institute, Oncopeptides (Sweden), Instituto de Biología Molecular y Celular de PlantasOCEAN (OP-103): Melflufen/Dexamethasone (Dex) Compared with Pomalidomide (Pom)/Dex in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Safety and Tolerability Analyses
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
